AQR CAPITAL MANAGEMENT LLC

Position in HUMA — Humacyte, Inc.

CIK 1167557 Greenwich, CT

Position in HUMA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,025,760

+$857,477 QoQ

Shares Held

2,597,134

+34.9% QoQ

Ownership

0.935%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 163 holders

Holding Since

Mar 2022

13 quarters on record

Voting authority Sole 99% Shared 0% None 1%

Healthcare · as of Jun 30, 2026

AQR CAPITAL MANAGEMENT LLC holds $5,658,888,286 across 216 Biotechnology names. HUMA ranks #122 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	1,126,080	$702,155,918
2	INCY	Incyte Corp	5,320,901	$603,177,333
3	EXEL	Exelixis, Inc.	11,023,943	$599,812,735
4	JAZZ	Jazz Pharmaceuticals plc	1,522,568	$366,893,205
5	BMRN	Biomarin Pharmaceutical Inc	5,699,541	$326,127,732
6	VRTX	Vertex Pharmaceuticals Inc / Ma	616,170	$306,070,117
7	RVMD	Revolution Medicines, Inc.	1,295,450	$242,611,869
8	RPRX	Royalty Pharma plc	4,305,412	$241,404,446

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,025,760	2,597,134	+34.9%	Shares	Defined	2026-08-14
2026-03-31	$1,168,283	1,924,691	+5590.3%	Shares	Other	2026-05-15
2025-12-31	$32,503	33,824	-86.9%	Shares	Other	2026-02-17
2025-09-30	$449,032	258,066	-59.3%	Shares	Other	2025-11-14
2025-06-30	$1,326,468	634,675	+4259.9%	Shares	Other	2025-08-14
2025-03-31	$24,818	14,557	-72.1%	Shares	Other	2025-05-15
2024-12-31	$263,114	52,102	-22.3%	Shares	Defined	2025-02-14
2024-09-30	$364,604	67,023	-73.9%	Shares	Defined	2024-11-14
2024-06-30	$1,230,441	256,342	+1018.4%	Shares	Other	2024-08-14
2024-03-31	$71,280	22,920	-47.1%	Shares	Defined	2024-05-15
2023-12-31	$123,076	43,337	+136.0%	Shares	Other	2024-02-14
2022-06-30	$58,954	18,366	-9.4%	Shares	Defined	2022-08-15
2022-03-31	$143,169	20,279	—	Shares	Defined	2022-05-16
No filing history on record for this holder in this stock.